Dr. Beth Karlan is a leader in the field of research on early detection of ovarian cancer. She has received research grants from the Department of Defense, National Institutes of Health and the American Cancer Institute. Her research interests include the genetic definition and phenotypic determinants of human ovarian carcinomas, molecular biomarker discovery and inherited cancer susceptibility. This year, she is our winner of the Rosalind Franklin Excellence in Ovarian Cancer Research Award due to her commitment to innovative ovarian cancer research.
Related Topics
Global Research Push Resonates Across Airwaves
News of the newly launched Global Ovarian Cancer Research Consortium — and its inaugural AI Accelerator Grant — is spreading quickly, with media outlets across the country taking notice. The … Continued
New Global Ovarian Cancer Research Consortium Joins Forces with Microsoft’s AI for Good Lab to Launch First-Of-Its-Kind $1M Global Grant to Improve Survival Rates
Four leading ovarian cancer research charities from four countries are funding a new AI Accelerator Grant in partnership with Microsoft’s AI for Good Lab to supercharge the next cancer research … Continued
OCRA’s Health Equity Research Grant Recipients
In the newest installment of our continuing introduction of our 2025 grantees, Ovarian Cancer Research Alliance (OCRA) is proud to highlight the three recipients of our 2025 Health Equity Research Grants, … Continued